Skip to main content

Table 2 Quantitative dataset characteristics. (a) Top row reports the number of VOIHEALTHY and related volume value (mean and standard deviation) for both pre- and post-treatment dataset, and the middle row refers to VOITUMOR; while the bottom row illustrates the data related to VOILUNGS with volumes values after the shrinkage process for both 166Ho-only and 166Ho-DI. b) median and quartile deviation of mean absorbed dose recovered in VOIs, for both 166Ho-only and 166Ho-DI are reported. First row refers to VOIHEALTHY, second to VOITUMOR, and third to VOILUNGS, respectively

From: Quantitative 166Ho-microspheres SPECT derived from a dual-isotope acquisition with 99mTc-colloid is clinically feasible

(a)

Pre-treatment

Post-treatment

VOI

Number

Volume

Number

Volume

Healthy

26

27.57 ml

32

27.57 ml

Tumor

21

27.50 ml ± 3.91

23

26.27 ml ± 2.23

Lungs

26

2399.30 ml ± 971.77 (166Ho-Only)

2182.47 ml ± 794.58 (166Ho-DI)

31

2578.09 ml ± 1026.67 (166Ho-Only)

2263.47 ml ± 841.22 (166Ho-DI)

(b)

166Ho-only

166Ho-DI

VOI

Median

Quartile deviation (IQR/2)

Median

Quartile deviation (IQR/2)

Healthy

27.12 Gy

7.08 Gy

26.22 Gy

8.00 Gy

Tumor

116.27 Gy

44.91 Gy

108.96 Gy

46.00 Gy

Lungs

2.99 Gy

0.99 Gy

3.88 Gy

1.07 Gy